Home › Funds › Nextech Invest Ltd. › ORIC
Nextech Invest Ltd. position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
Nextech Invest Ltd. reported holding 7,162,637 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$77.6M, representing 3.68% of its reported portfolio and ranking #6 among its reported holdings. Nextech Invest Ltd. has disclosed ORIC holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nextech Invest Ltd.'s ORIC position evolved
Nextech Invest Ltd. first disclosed a stake in ORIC in Q1 2025 at 5,285,714 shares (US$29.5M). The position peaked in Q1 2026 at 7,162,637 shares, worth US$90.8M. Across 6 filings, Nextech Invest Ltd. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 7,162,637 shares valued at US$77.6M. Notable position changes include a 36% increase in Q2 2025 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 5.29M | $29.49M | New |
| Q2 2025 | 7.16M | $72.70M | Add |
| Q3 2025 | 7.16M | $85.95M | Hold |
| Q4 2025 | 7.16M | $58.59M | Hold |
| Q1 2026 | 7.16M | $90.75M | Hold |
| Q2 2026 | 7.16M | $77.57M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M), Venrock Adviser, LLC (US$46.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- EcoR1 Capital, LLC 6.73M sh · $72.87M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- Siren, L.L.C. 3.00M sh · $32.47M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Vivo Capital, LLC 1.85M sh · $20.02M · Q2 2026
- Defilade Capital Management, L.P. 1.05M sh · $11.35M · Q2 2026
More on Nextech Invest Ltd.
FAQ
How long has Nextech Invest Ltd. held ORIC?
Nextech Invest Ltd. has disclosed ORIC holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Nextech Invest Ltd.'s current position in ORIC?
As of Q2 2026, Nextech Invest Ltd. holds 7.16M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $77.57M, representing 3.68% of its reported portfolio and ranking #6.
Has Nextech Invest Ltd. been buying or selling ORIC?
In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in ORIC. The position peaked in Q1 2026 at 7.16M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, Venrock Adviser, LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.